Related Experiment Video
Updated: Jun 28, 2026

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
Published on: June 9, 2017
Roles of G protein and beta-arrestin in dopamine D2 receptor-mediated ERK activation
Wenying Quan1, Ju-Heon Kim1, Paul R Albert2
1Department of Pharmacology, College of Pharmacy, Chonnam National University, Kwang-Ju 500-757, Republic of Korea.
Abstract:
ERK activation by dopamine D(2) receptor (D(2)R) has been extensively characterized in various cell types including brain tissues. However, the involvement of beta-arrestin in the D(2)R-mediated ERK activation is not clear yet. Three different strategies were employed in this study to determine the roles of G protein or beta-arrestin in D(2)R-mediated ERK activation. The cellular level of beta-arrestins was reduced by RNA interference and pertussis toxin-insensitive Gi proteins were used to identify the G protein involved. Finally point mutations of D(2)R in which coupling with G protein was abolished but the interaction with beta-arrestin was increased, were employed to determine whether the affinity between D(2)R and beta-arrestin is a critical factor for beta-arrestin-mediated ERK activation. Our results show that G(i2) protein is involved in D(2)R-mediated ERK activation but beta-arrestins are either not involved or play minor role.
Insights
Dopamine D(2) receptor (D(2)R) mediated ERK activation primarily involves G(i2) proteins. Beta-arrestins play a minimal or no role in this signaling pathway, despite previous characterization in brain tissues.
Area of Science:
- Neuropharmacology
- Cellular Signaling
- Molecular Biology
Background:
- Dopamine D(2) receptor (D(2)R) signaling pathways, particularly ERK activation, are well-documented in various cell types, including brain tissues.
- The specific contribution of beta-arrestin proteins to D(2)R-mediated ERK activation remains incompletely understood.
- Understanding these pathways is crucial for elucidating neurotransmitter receptor function and developing targeted therapeutics.
Purpose of the Study:
- To elucidate the distinct roles of G protein and beta-arrestin in dopamine D(2) receptor (D(2)R)-mediated ERK activation.
- To determine if beta-arrestin interaction affinity is critical for ERK activation downstream of D(2)R.
- To differentiate between G protein-dependent and beta-arrestin-dependent signaling cascades.
Main Methods:
- Utilized RNA interference to reduce cellular beta-arrestin levels.
- Employed pertussis toxin-insensitive Gi proteins to identify the specific G protein involved in D(2)R signaling.
- Generated point mutations in D(2)R to uncouple G protein interaction while enhancing beta-arrestin binding, assessing the impact on ERK activation.
Main Results:
- Demonstrated the involvement of the G(i2) protein subtype in D(2)R-mediated ERK activation.
- Showed that beta-arrestins are either not involved or play a very minor role in this signaling pathway.
- Mutational analysis indicated that enhanced D(2)R-beta-arrestin interaction did not significantly drive ERK activation.
Conclusions:
- The primary mechanism for D(2)R-mediated ERK activation in the studied system relies on G(i2) protein signaling.
- Beta-arrestin-dependent signaling is not a major contributor to ERK activation downstream of the D(2)R.
- These findings clarify the signaling bias of the dopamine D(2) receptor concerning ERK pathway activation.
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
Activation and Inactivation of G Proteins
GPCRs Regulate Adenylyl Cylase Activity
Two...
Secondary Messengers in Hormone Action
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
GPCR Desensitization
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

